MeSH D006473 - postpartum hemorrhage
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Teva | Methylergonovine | Methylergonovine | 2019-03-20 | |||
| Novartis | Oxytocin | Syntocinon | 1982-01-01 | |||
| Pfizer | Carboprost tromethamine | Hemabate | 1982-01-01 | |||
| Dr Reddys Laboratories | Carboprost tromethamine | Carboprost Tromethamine | 2019-07-02 | |||
| Oxytocin | Oxytocin | 2008-01-24 | ||||
| Rising Pharmaceuticals | Methylergonovine | Methylergonovine | 2021-01-15 | |||
| Breckenridge Pharmaceutical | Methylergonovine | Methylergonovine | 2010-09-13 | |||
| Amneal Pharmaceuticals | Carboprost tromethamine | Carboprost Tromethamine | 2022-01-27 | |||
| Methylergonovine | Methylergonovine | 2018-09-10 |
1
2
3
4
>
Clinical Trials
Historical Success Rate
Phase 1
86%6/7
Phase 2
71%5/7
Phase 3
71%10/14
Approved: 6Overall Success rate: 44%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use